TXMDNasdaq United States
Market cap
$23.959 M
$2.07 -0.96%
Close of 7 Aug 2026
Revenue
$1.76M
#3454 by revenue
Earnings
-$569.0K
Loss-making
Shares outstanding
11,574,362
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for TherapeuticsMD are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.